Search Results

There are 6117 results for: content related to: Nineteenth annual symposia on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders

  1. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  2. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  3. Poster Session 3

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S517–S613,

    Version of Record online : 20 SEP 2006, DOI: 10.1002/mds.21248

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  5. You have free access to this content
    Ropinirole, a Non-Ergoline Dopamine Agonist

    CNS Drug Reviews

    Volume 11, Issue 3, September 2005, Pages: 253–272, Wolfgang H. Jost and Dieter Angersbach

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2005.tb00046.x

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  7. PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1259–1265, Fabrizio Stocchi, Luigi Giorgi, Brian Hunter and Anthony HV Schapira

    Version of Record online : 5 APR 2011, DOI: 10.1002/mds.23498

  8. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  9. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001517

  10. Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson’s disease

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 571–577, N. Hattori, K. Hasegawa and T. Sakamoto

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01336.x

  11. You have free access to this content
    Comparison of ropinirole controlled- and immediate-release in Japanese patients with advanced Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 1, January 2015, Pages: 18–24, Nobutaka Hattori, Hiroshi Nishioka, Kazuko Hasegawa and on behalf of the SWAN Study Investigators

    Version of Record online : 25 NOV 2014, DOI: 10.1111/ncn3.128

  12. DA agonists - Non-Ergot derivaties: Ropinirole

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S98–S102,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5570

  13. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease

    Movement Disorders

    Volume 24, Issue 14, 30 October 2009, Pages: 2121–2127, Kelly E. Lyons and Rajesh Pahwa

    Version of Record online : 18 SEP 2009, DOI: 10.1002/mds.22750

  14. You have free access to this content
    POSTER SESSION 1, SUNDAY 24 AUGUST

    European Journal of Neurology

    Volume 15, Issue s3, August 2008, Pages: 32–220,

    Version of Record online : 12 AUG 2008, DOI: 10.1111/j.1468-1331.2008.02285.x

  15. Ropinirole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001516

  16. You have free access to this content
    D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways

    FEBS Letters

    Volume 582, Issue 5, March 05, 2008, Pages: 603–610, Sheng Chen, Xiaojie Zhang, Dehua Yang, Yunlan Du, Liang Li, Xuping Li, Ming Ming and Weidong Le

    Version of Record online : 31 JAN 2008, DOI: 10.1016/j.febslet.2008.01.028

  17. Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L-Dopa in Patients with Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 2, February 1999, Pages: 150–156, Dr. Anne C. Taylor, Dr. Almisbah Beerahee, Dr. David R. Citerone, Dr. Matthew J. Cyronak, Dr. Terry J. Leigh, Dr. Katherine L. Fitzpatrick, Dr. Arturo Lopez-Gil, Dr. Sarosh D. Vakil, Dr. Eileen Burns and Dr. Graham Lennox

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.3.150.30927

  18. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

    Movement Disorders

    Volume 13, Issue 1, January 1998, Pages: 46–51, Prof. Amos D. Korczyn, David J. Brooks, Ehrout R. Brunt, Warner H. Poewe, Olivier Rascol and Fabrizzio Stocchi

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130112

  19. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  20. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

    Annals of Neurology

    Volume 54, Issue 1, July 2003, Pages: 93–101, Alan L. Whone, Ray L. Watts, A. Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E. Lang, Olivier Rascol, Maria J. Ribeiro, Philippe Remy, Werner H. Poewe, Robert A. Hauser and David J. Brooks

    Version of Record online : 14 MAY 2003, DOI: 10.1002/ana.10609